700 related articles for article (PubMed ID: 32360286)
1. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19.
Yang Y; Shen C; Li J; Yuan J; Wei J; Huang F; Wang F; Li G; Li Y; Xing L; Peng L; Yang M; Cao M; Zheng H; Wu W; Zou R; Li D; Xu Z; Wang H; Zhang M; Zhang Z; Gao GF; Jiang C; Liu L; Liu Y
J Allergy Clin Immunol; 2020 Jul; 146(1):119-127.e4. PubMed ID: 32360286
[TBL] [Abstract][Full Text] [Related]
2. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
[TBL] [Abstract][Full Text] [Related]
3. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
Front Immunol; 2021; 12():691879. PubMed ID: 34163488
[TBL] [Abstract][Full Text] [Related]
4. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
[TBL] [Abstract][Full Text] [Related]
5. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
Chi Y; Ge Y; Wu B; Zhang W; Wu T; Wen T; Liu J; Guo X; Huang C; Jiao Y; Zhu F; Zhu B; Cui L
J Infect Dis; 2020 Aug; 222(5):746-754. PubMed ID: 32563194
[TBL] [Abstract][Full Text] [Related]
6. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
[TBL] [Abstract][Full Text] [Related]
7. Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19.
Sugiyama M; Kinoshita N; Ide S; Nomoto H; Nakamoto T; Saito S; Ishikane M; Kutsuna S; Hayakawa K; Hashimoto M; Suzuki M; Izumi S; Hojo M; Tsuchiya K; Gatanaga H; Takasaki J; Usami M; Kano T; Yanai H; Nishida N; Kanto T; Sugiyama H; Ohmagari N; Mizokami M
Gene; 2021 Jan; 766():145145. PubMed ID: 32941953
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of cytokine/chemokine responses for the disease severity and management in children and adult cases with COVID-19.
Ozsurekci Y; Aykac K; Er AG; Halacli B; Arasli M; Oygar PD; Gürlevik S; Cura Yayla BC; Karakaya J; Alp A; Topeli A; Cengiz AB; Akova M; Ceyhan M
J Med Virol; 2021 May; 93(5):2828-2837. PubMed ID: 33225509
[TBL] [Abstract][Full Text] [Related]
9. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
Yang M; Chen X; Xu Y
Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
[TBL] [Abstract][Full Text] [Related]
11. Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19.
Li J; Li M; Zheng S; Li M; Zhang M; Sun M; Li X; Deng A; Cai Y; Zhang H
Biomark Med; 2020 Jul; 14(10):827-837. PubMed ID: 32490680
[No Abstract] [Full Text] [Related]
12. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological investigation of patients with severe COVID-19.
Li S; Jiang L; Li X; Lin F; Wang Y; Li B; Jiang T; An W; Liu S; Liu H; Xu P; Zhao L; Zhang L; Mu J; Wang H; Kang J; Li Y; Huang L; Zhu C; Zhao S; Lu J; Ji J; Zhao J
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32427582
[TBL] [Abstract][Full Text] [Related]
15. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.
Ling L; Chen Z; Lui G; Wong CK; Wong WT; Ng RWY; Tso EYK; Fung KSC; Chan V; Yeung ACM; Hui DSC; Chan PKS
Front Immunol; 2021; 12():763292. PubMed ID: 34938289
[TBL] [Abstract][Full Text] [Related]
17. IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection.
Gadotti AC; de Castro Deus M; Telles JP; Wind R; Goes M; Garcia Charello Ossoski R; de Padua AM; de Noronha L; Moreno-Amaral A; Baena CP; Tuon FF
Virus Res; 2020 Nov; 289():198171. PubMed ID: 32979474
[TBL] [Abstract][Full Text] [Related]
18. Association between cytokine profiles and lung injury in COVID-19 pneumonia.
Chen LD; Zhang ZY; Wei XJ; Cai YQ; Yao WZ; Wang MH; Huang QF; Zhang XB
Respir Res; 2020 Jul; 21(1):201. PubMed ID: 32727465
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunological features of severe and moderate coronavirus disease 2019.
Chen G; Wu D; Guo W; Cao Y; Huang D; Wang H; Wang T; Zhang X; Chen H; Yu H; Zhang X; Zhang M; Wu S; Song J; Chen T; Han M; Li S; Luo X; Zhao J; Ning Q
J Clin Invest; 2020 May; 130(5):2620-2629. PubMed ID: 32217835
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]